Lupus Erythematosus, Systemic: all 1,222 studies
Page 13 of 13. Open to participants first (399), then studies with results posted, then the rest; newest registration first within each.
- Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune DisordersCompletedNCT00010335Phase 1
- Role of Altered CD40-Ligand Gene Transcription in Systemic Lupus ErythematosusStatus unknownNCT00008749
- Study of the Predictors of the Course and Early Outcome of Patients With Systemic Lupus Erythematosus: Nature Versus NurtureCompletedNCT00006134
- Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus ErythematosusCompletedNCT00006133Not applicable
- Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune DiseasesStatus unknownNCT00006055Not applicable
- High-Dose Intravenous (IV) Cyclophosphamide Versus Monthly IV CyclophosphamideCompletedNCT00005778Phase 3
- Lupus Cohort--Thrombotic Events and Coronary Artery DiseaseCompletedNCT00005436
- Phase II/III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Mild to Moderate Systemic Lupus ErythematosusCompletedNCT00004795Phase 2/3
- Study of Individualized Instruction Versus Pamphlet in Systemic Lupus ErythematosusCompletedNCT00004756Not applicable
- Phase II Study of Long-Term Dehydroepiandrosterone for Systemic Lupus ErythematosusCompletedNCT00004665Phase 2
- Epidemiologic Study of Reproductive Outcome in Women With Systemic Lupus ErythematosusCompletedNCT00004663
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Active Systemic Lupus ErythematosusCompletedNCT00004662Phase 3
- Phase II Pilot Study of Cytarabine for Refractory Systemic Lupus ErythematosusCompletedNCT00004643Phase 2
- Ultraviolet Light Therapy for Systemic Lupus ErythematosusStatus unknownNCT00004375Phase 2
- A Pilot Trial of Topical Thalidomide for the Management of Chronic Discoid Lupus ErythematosusCompletedNCT00001680Phase 2
- Cyclophosphamide and Fludarabine to Treat Lupus NephritisCompletedNCT00001676Phase 1
- Drug Therapy in Lupus NephropathyCompletedNCT00001212Phase 2
- Serologically Active, Clinically Stable Systemic Lupus ErythematosusCompletedNCT00000421Phase 2
- Safety of Estrogens in Lupus: Birth Control PillsCompletedNCT00000420Phase 3
- Safety of Estrogens in Lupus: Hormone Replacement TherapyTerminatedNCT00000419Phase 3
- Psychoeducational Approach to Improve Health in LupusCompletedNCT00000417Phase 2
- Prevention of Arthritis-Related Work DisabilityCompletedNCT00000416Not applicable